A detailed history of Bell & Brown Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bell & Brown Wealth Advisors, LLC holds 9,842 shares of AMGN stock, worth $2.6 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
9,842
Previous 9,793 0.5%
Holding current value
$2.6 Million
Previous $3.06 Million 3.66%
% of portfolio
1.24%
Previous 1.25%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $15,159 - $16,531
49 Added 0.5%
9,842 $3.17 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $59,381 - $72,164
-226 Reduced 2.26%
9,793 $3.06 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $187,133 - $225,893
696 Added 7.47%
10,019 $2.85 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $210,952 - $237,979
825 Added 9.71%
9,323 $2.69 Million
Q2 2023

Aug 15, 2023

SELL
$214.27 - $253.37 $11,570 - $13,681
-54 Reduced 0.63%
8,498 $1.89 Million
Q1 2023

Apr 14, 2023

SELL
$225.79 - $275.2 $38,384 - $46,784
-170 Reduced 1.95%
8,552 $2.07 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $24,048 - $30,556
-105 Reduced 1.19%
8,722 $2.29 Million
Q3 2022

Oct 26, 2022

SELL
$224.46 - $253.15 $14,140 - $15,948
-63 Reduced 0.71%
8,827 $1.99 Million
Q2 2022

Jul 22, 2022

SELL
$230.71 - $256.74 $44,988 - $50,064
-195 Reduced 2.15%
8,890 $2.16 Million
Q1 2022

May 02, 2022

SELL
$219.27 - $242.57 $36,179 - $40,024
-165 Reduced 1.78%
9,085 $2.2 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $138,420 - $158,409
696 Added 8.14%
9,250 $2.2 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $48,185 - $56,454
-227 Reduced 2.59%
8,554 $1.82 Million
Q3 2020

Oct 23, 2020

SELL
$234.65 - $260.95 $27,219 - $30,270
-116 Reduced 1.3%
8,781 $2 Million
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $26,506 - $32,527
-134 Reduced 1.48%
8,897 $2.16 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $46,835 - $62,116
-257 Reduced 2.77%
9,031 $2.16 Million
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $42,572 - $54,720
-225 Reduced 2.37%
9,288 $2.24 Million
Q3 2019

Oct 09, 2019

BUY
$174.11 - $208.62 $2,611 - $3,129
15 Added 0.16%
9,513 $1.83 Million
Q2 2019

Aug 06, 2019

BUY
$166.7 - $195.41 $35,840 - $42,013
215 Added 2.32%
9,498 $1.75 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $10,852 - $12,232
60 Added 0.65%
9,283 $1.76 Million
Q4 2018

Feb 22, 2019

SELL
$178.4 - $208.25 $2.59 Million - $3.02 Million
-14,492 Reduced 61.11%
9,223 $1.8 Million
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $2.63 Million - $3.06 Million
14,717 Added 163.56%
23,715 $4.62 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $21,308 - $24,022
-115 Reduced 1.26%
8,998 $1.74 Million
Q2 2018

Jul 31, 2018

BUY
$166.05 - $186.51 $24,907 - $27,976
150 Added 1.67%
9,113 $1.68 Million
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $33,886 - $39,600
-200 Reduced 2.18%
8,963 $1.53 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $1.55 Million - $1.73 Million
9,163
9,163 $1.59 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bell & Brown Wealth Advisors, LLC Portfolio

Follow Bell & Brown Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell & Brown Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bell & Brown Wealth Advisors, LLC with notifications on news.